Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Tassone

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2009
FMR1 premutation in females diagnosed with multiple sclerosisL Zhang, S Coffey, L L Lua, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 13, 2009
Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriersP E Adams, J S Adams, D V Nguyen, et al.
Neurology|December 7, 2007
FMR1 CGG repeat length predicts motor dysfunction in premutation carriersM A Leehey, E Berry-Kravis, C G Goetz, et al.
Brain : a Journal of Neurology|December 8, 2005
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)C M Greco, R F Berman, R M Martin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2022
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experienceG Avallone, F Cavallo, C Astrua, et al.
American Journal of Human Genetics|April 6, 2004
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutationR J Hagerman, B R Leavitt, F Farzin, et al.
Journal of Nephrology|September 24, 1999
Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patientsL S Malatino, F A Benedetto, F Mallamaci, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 15, 2017
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia SyndromeJ Y Wang, A M Trivedi, N R Carrillo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2009
FMR1 premutation in females diagnosed with multiple sclerosisL Zhang, S Coffey, L L Lua, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 13, 2009
Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriersP E Adams, J S Adams, D V Nguyen, et al.
Neurology|December 7, 2007
FMR1 CGG repeat length predicts motor dysfunction in premutation carriersM A Leehey, E Berry-Kravis, C G Goetz, et al.
Brain : a Journal of Neurology|December 8, 2005
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)C M Greco, R F Berman, R M Martin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2022
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experienceG Avallone, F Cavallo, C Astrua, et al.
American Journal of Human Genetics|April 6, 2004
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutationR J Hagerman, B R Leavitt, F Farzin, et al.
Journal of Nephrology|September 24, 1999
Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patientsL S Malatino, F A Benedetto, F Mallamaci, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 15, 2017
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia SyndromeJ Y Wang, A M Trivedi, N R Carrillo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 13